| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.28 | 0.04 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.23 | 0.2 |